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The GABAergic system is critically involved in the modulation of anxiety levels, and dysfunction of GABA- 
ergic neurotransmission appears to be involved in the development of generalized anxiety disorder. Precursor 
cells from the medial ganglionic eminence (MGE) have the ability to migrate and differentiate into inhibitory 
GABAergic interneurons after being transplanted into the mouse brain. Thus, transplantation of interneuronal 
precursor cells derived from the MGE into a postnatal brain could modify the neuronal circuitry, increasing 
GABAergic tone and decreasing anxiety-like behavior in animals. Our aim was to verify the in vivo effects of 
transplanted MGE cells by evaluating anxiety-like behavior in mice. MGE cells from 14-day green fluorescent 
protein (GFP) embryos were transplanted into newborn mice. At 15, 30, and 60 days posttransplant, the animals 
were tested for anxiety behavior with the elevated plus maze (EPM) test. Our results show that transplanted 
cells from MGE were able to migrate to different regions of the brain parenchyma and to differentiate into 
inhibitory interneurons. The neuronal precursor cell transplanted animals had decreased levels of anxiety, indi-
cating a specific function of these cells in vivo. We suggested that transplantation of MGE-derived neuronal 
precursors into neonate brain could strengthen the inhibitory function of the GABAergic neuronal circuitry 
related to anxiety-like behavior in mice.
Key words: GABAergic neuron (GABA); Medial ganglionic eminence (MGE);  
Green fluorescent protein (GFP); Cell differentiation; Anxiolysis
INTRODUCTION
The medial and caudal ganglionic eminences (MGE, 
CGE) of the ventral telencephalon in the embryonic brain 
give rise to the majority of the cerebral cortex’s inhibitory 
interneurons (25,40–42). In the developing brain, these 
cells have the potential to migrate from these regions and 
integrate into the circuitry of the striatum, cortex, hip-
pocampus, and olfactory bulb (40). When transplanted 
into a neonate brain, MGE-derived precursor cells pre- 
serve their ability to migrate and differentiate into 
g-aminobutyric acidergic (GABAergic) interneurons, 
establishing functional inhibitory synapses with preexist- 
ing neurons and modifying the inhibitory tone in the 
host brain (1,5,40). 
It is widely believed that GABAergic circuits are criti-
cally involved in the modulation of anxiety levels (28). A 
reduction in GABAergic neurotransmission could contrib-
ute to the emergence of anxiety disorders (2). Moreover, 
the anxiolytic effect of drugs that act on the GABA recep-
tors (32) or the engraftment of GABAergic cells into the 
amygdaloid nuclei (11) provides strong evidence that 
GABA dysfunction underlies anxiety states. Currently, 
investigations are being intensively conducted to better 
understand the GABAergic circuits that are involved in 
the regulation of anxiety levels and mood disorders. The 
amygdala has been considered to be directly involved in 
anxiety and the emotion of fear since the early studies 
of Kluver and Bucy (22 for review). However, investiga-
tions over the last two decades have produced advances 
toward determining the neuroanatomy of other circuits 
related to the behavior of fear and anxiety, which con-
nect the amygdala with other regions of the brain (33,36). 
Studies have shown that, in addition to the amygdala, 
the temporal and prefrontal cortices also play a critical 
role in the expression of anxiety and fear conditioning 
(3,4,6,16,17,21,27).
The focus of this study was to investigate the effects of 
transplanted cells in vivo in three different phases of devel-
opment. We hypothesized that interneuronal precursor 
cells transplanted into the immature brain could integrate 
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into the host neural circuitry and have inhibitory effects 
that would influence the overall level of anxiety in mice 
throughout the maturation of the central nervous system. 
Since its introduction by Handley and Mithani (18) and 
its experimental validation for rats (30) and mice (23), 
the elevated plus maze (EPM) has been most extensively 
used to assess the anxiolytic and anxiogenic effects of 
drugs and to measure levels of spontaneous anxiety-like 
behavior (10,20,31). In the present study, we evaluated the 
EPM behavior of mice that were neonatally transplanted 
with MGE-derived cells. The test was performed at three 
different times for posttransplantations (15, 30, and 60 
days). GABAergic neurotransmission is also involved in 
memory (24) and motor function (19), and so the behav-
ior of transplanted mice was also quantified in the passive 
avoidance memory task, and their general activity was 
quantified in the open-field test. Immunohistochemistry 
was also performed to confirm the ability of precursor cells 
from the MGE to migrate and differentiate into inhibitory 
GABAergic interneurons after being transplanted into the 
mouse brain. 
MATeRIALs AND MeTHODs
All of the animals were housed in a pathogen-free 
facility and were maintained in accordance with the 
Guide for the Care and Use of Laboratory Animals 
(National Research Council). Experimental protocols 
were approved by the Animal Care and Ethics Committee 
of UNIFESP/SP. 
MGE Extraction and Transplantation
Transgenic mice expressing enhanced green fluores-
cent protein (GFP) cDNA under the control of a chicken 
b-actin promoter and cytomegalovirus enhancer, provided 
by CEDEME (Center for the Development of Animal 
Models in Biology and Medicine at Universidade Federal 
de São Paulo, São Paulo, Brazil), were used as MGE 
donors. For tissue extraction and cell dissociation, ven-
tricular and subventricular layers of MGE of E13.5 GFP 
transgenic mouse embryos were dissected. The tissue 
was removed and mechanically dissociated by pipetting 
and centrifugation; the cells were washed with medium 
[Dulbecco’s modified Eagle’s medium (DMEM); Gibco, 
Grand Island, NY, USA] containing DNase I (10 mg/ml; 
Invitrogen, Carlsbad, CA, USA); they were then centri-
fuged and resuspended in 4–5 µl of cold culture medium. 
We determined the cell number and viability by the try-
pan blue (Gibco) exclusion method. The cell suspension 
was placed in a Narishige microinjector (Narishige Sci- 
entific Intrument Laboratory, Tokyo, Japan) guided with 
a stereotaxic apparatus. Neonatal C57/Bl6 mice [P3; 
CEDEME (Centro de Desenvolvimento de Modelos 
Experimentais em Medicina e Biologia) UNIFESP, 
São Paulo - SP, Brazil] (n = 28) were anesthetized by 
hypothermia (-4°C), and 5 ´  104 to 1.5 ´  105 of the cells 
in a 0.4-µl volume were bilaterally injected at a 45° angle 
into the neocortex (layers 3–4) of each mouse. The cell 
infusion was made in the superficial layers of neocortex 
(up to fourth layer) and not directly into brain structure 
that are commonly believed to be associated with anxi-
ety, such as amygdala, to avoid track lesion in profound 
structures and further brain damage. Within this context, 
the migratory potential of these cells and their effective 
dispersion throughout the neocortex have been demon-
strated (1,5,40,42). The age-matched control group was 
injected with medium (n = 26) or with a similar volume of 
dead cells (by repeated frost and thaw cycles) as a control 
for the inflammatory response or GFP toxicity (n = 24). 
Behavioral Tests
The behavioral tests were performed at 15, 30, and 60 
days after transplantation with MGE cells (respectively, 
n = 9, n = 6, and n = 13), medium (n = 9, n = 6, and n = 11), 
or dead cells (n = 6, n = 9, and n = 9). The animals were 
evaluated using EPM tests and open-field (OF) tests at 
each time point, whereas the passive avoidance (PA) test 
was performed only at 60 days. The tests were performed 
during the light period (14:00–17:00 h). The behavior of 
each animal was videotaped by a video camera located 
150 cm above the apparatus. Videotapes were later 
watched and analyzed by a trained observer. All of the 
observations were conducted blindly.
Elevated Plus Maze (EPM) Test
The Elevated Plus Maze (EPM; AVS, Solução Inte-
grada Comercial, São Carlos-SP, Brazil) apparatus con- 
sisted of two open (28.5 ´  7 cm) and two enclosed (28.5 ´  
7 ´  14 cm) arms made of wood, which were arranged 
in such a way that the two pairs of identical arms were 
opposite to each other. The open arms were bounded by 
1-cm-high ledges on the border of the arms. The maze 
was raised to a height of 50 cm above the floor. Each 
mouse was placed in the center of the apparatus, and we 
recorded the number of entries into the open arms and 
the number of entries into the closed arms. In addition, 
we recorded the time spent in the open arms and the time 
spent in the closed arms. The percentage of time spent 
in the open arms and the entries into the open arms [i.e., 
(the time in or entries into the open arms) / (the time in 
or entries into the open arms + the time in or entries into 
the closed arms)] were recorded as anxiety-like behavior 
indexes, and the number of entries into either arm of the 
apparatus was used as an index of general activity.
Open-Field (OF) Test
The open-field (OF; AVS) apparatus consisted of a cir-
cular arena 85 cm in diameter, divided into 25 segments 
of approximately equal area by black painted lines on the 
ANXIOLYTIC BEHAVIOR AFTER MGE CELL TRANSPLANTATION 1239
white floor. The arena was bound by a wall 50 cm high. 
The central zone was defined as the central compartment 
of the floor, which was centrally located 6 cm from the 
perimeter of the chamber walls. The parameters assessed 
for the present studies were the frequency of entering the 
center and the time spent in the center and in the periphery. 
Each mouse was individually placed in the center of the OF 
apparatus, and the ambulation scores (the number of areas 
entered with all four paws) were tallied for 5 min. Fecal 
pellets were removed, and the floor was wiped with clean 
damp tissues after every occupation. The motor activity 
was calculated using the distance moved in the OF. All of 
the testing was conducted under standard room lighting.
Passive Avoidance (PA) Test
The passive avoidance (PA; AVS) apparatus consisted 
of a dark compartment and an illuminated compartment 
(both measuring 10 cm ´  10 cm in an area with a wall 
height of 20 cm) that were separated by a guillotine door. 
On the first day, the animal was placed in the illuminated 
compartment for an acclimatization period of 30 s, and 
then the door was opened. As the mouse entered the dark 
compartment (four paws), the door was closed and a 
single low-intensity foot shock (0.5 mA; 5 s) was deliv-
ered through the stainless steel rods. The mouse was then 
removed from the darkened chamber 10 s after the shock. 
The session was repeated at 90-min time intervals from 
the first training trial. Twenty-four hours later, the mouse 
was again placed in the illuminated compartment, and the 
latency to enter the dark chamber was measured, with a 
cutoff at 300 s. Mice that did not enter into the dark com-
partment within 300 s were removed from the apparatus 
and assigned a latency score of 300 s. A shock was not 
delivered in the retention trial. The time taken for a mouse 
to enter the dark compartment after the door opened was 
defined as the latency time for both the acquisition and 
the retention trials (37).
Immunohistochemistry
At the end of the behavioral tests, the animals were 
deeply anesthetized with 10% chloral hydrate (400 mg/
kg, IP; Merck, Rio de Janeiro- RJ, Brazil) and perfused 
through the heart with 50 ml of phosphate-buffered saline 
(PBS, Sigma-Aldrich, St. Louis, MO, USA) followed by 
200 ml of 4% paraformaldehyde (Synth, São Paulo - SP, 
Brazil) at 4°C. Coronal brain cryostat sections (35 µm 
thick) were made between bregma 0.98 and bregma 
-3.28 mm according to the stereotaxic coordinates of 
the mouse brain atlas (29). To visualize transplanted 
MGE cells, slices were processed for immunofluores-
cence for GFP and were double-labeled with interneu-
ronal markers [neuropeptide Y (NPY), calretinin (CR), 
and parvalbumin (PV)]. The sections were incubated for 
2 h with an anti-GFP AlexaFluor 488-conjugated antibody 
(1:600; Molecular Probes/Invitrogen, Eugene, OR, USA), 
followed by an overnight incubation with rabbit anti- 
bodies against NPY (1:1,500, Molecular Probes), CR 
(1:2,000, Molecular Probes), and PV (1:2,000, Molecular 
Probes). The sections were then incubated with anti-rabbit 
IgG AlexaFluor 546-conjugated antibodies (1:600, Molec- 
ular Probes/Invitrogen) for 1 h. All of the sections were 
mounted using a nuclear-counterstaining, fluorescence- 
preserving mounting medium containing DAPI (Vector 
Laboratories, Burlingame, CA, USA). The slides were 
examined using fluorescence (Nikon 80i; Nikon, Melville, 
NY, USA) and confocal (Olympus FluoView 1000; Olym- 
pus, Center Valley, PA, USA) microscopes. In each sec-
tion, double-labeled cells were qualitatively evaluated 
for their localization in the brain areas of interest and for 
their morphology.
The estimation of GFP cells was sampled in five coro-
nal sections for the neocortex, striatum, hippocampus, 
amygdala, thalamus, and corpus callosum. In counted 
slices, cells could be detected at ~1 mm from the site of 
injection in adult animals (P30 and P60). Images of 10 
random, nonoverlapping fields were captured and quanti-
fied for each region. The same counting protocol was used 
to estimate the percentage of double-stained GFP+/NPY+, 
GFP+/CR+, and GFP+/PV+ cells. All of the images were 
captured and digitized using the Nikon ACT-1 v.2 system 
or the Olympus OLYMPUS FLUOVIEW Ver.2.0b Viewer 
(FV10-ASW) software. 
Statistical Analyses
Statistical analysis of the behavior was performed 
using analysis of variance (ANOVA) followed by Tukey’s 
multiple comparison post hoc test (GraphPad Prism v. 4.0, 
GraphPad Software, Inc., San Diego, CA, USA) to pro-
duce a comparison between MGE-transplanted, nontrans-
planted, and “dead cells” animals. A significance level of 
5% was assumed.
ResULTs
Anxiety-Like Behavior
The anxiety-like behavior of the animals was evalu-
ated by the EPM test at three different time points after 
transplantation (MGE15, MGE30, and MGE60) and com-
pared to age-matched medium-injected (CTRL) and dead 
cell-injected (DC) animals (CTRL15, CTRL30, CTRL60 
and DC15, DC30, DC60, respectively) (Fig. 1A, B). At 
15 days posttransplantation, there were no significant dif-
ferences in the percentage of entries and the time spent 
in the open arms when compared with the CTRL and DC 
groups), although there was a trend toward an increase in 
the percentage of time spent in the open arms at this age 
posttransplantation (p = 0.0893). Significant differences 
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were detected at 30 and 60 days posttransplantation, 
indicating a reduction in anxiety levels in the MGE-
transplanted animals when compared to the other groups. 
Thirty days after transplantation, there was a reduced-
anxiety behavioral pattern in the MGE30 group, which 
was indicated by a significant increase in the percentage 
of time spent in the open arms (p = 0.0004) (Fig. 1B). At 
60 days after transplantation (MGE60 group), there was 
a significant increase in the percentage of time spent 
the open arms (p = 0.0086) and entries in the open arms 
(p = 0456) (Fig. 1C, F). Concerning the total number of 
entries in both the open and closed arms, there were no 
significant differences at the three evaluated time points 
after transplantation. Closed arm entries has been pro-
posed as an alternative index of general activity in the 
plus maze (15,34), so this parameter was also quantified, 
but no significant differences were revealed at any of the 
time points (data not shown).
Motor Activity and Memory Test
The motor activity of the transplanted mice was 
assessed using the open-field test. There was no signifi-
cant difference in the general activity of the MGE animals 
for any of the parameters that were examined. Indeed, 
the total distance traveled in 5 min was similar for the 
three groups, and in addition, there was no significant 
difference in the number of visited squares and the time 
spent in the center of the OF between the groups at the 
three different time points. 
The PA test (a memory test) is based on the principle 
that performing certain behaviors leads to an unpleasant 
consequence; thus, the animal will avoid the repetition of 
that behavior, unless it has a memory deficit. There was no 
memory deficit measured by the acquisition test (90 min 
after training) or the retention test (24 h after training) in 
the MGE-transplanted animals at 60 days posttransplanta-
tion when compared to CTRL animals. The percentage of 
animals that reached the cutoff score (300 s) at both 90 min 
and 24 h after the training was 75% and 42%, respectively, 
in MGE60 animals and 50% in the CTRL animals. We 
noted an increase, although it was not statistically signifi-
cant, in the latency before entering the dark compartment 
for the MGE60 animals when they were tested 90 min after 
training (p = 0.074). We did not test animals at 15 and 30 
days because of the aversive nature of the test. 
The anxiolytic behavioral pattern of the MGE-
transplanted animals was not likely the result of locomo-
tor hyperactivity because the total number of entries and 
the open-field activity revealed no differences between 
the groups. The assessment of memory by the PA test 
indicated that there was no change in the short- or long-
term memories between the groups. These findings favor 
Figure 1. Elevated plus maze behavior of the control (CTRL), dead cell-transplanted (DC), and medial ganglionic eminence (MGE)-
transplanted (MGE) animals. The percentage of time spent in the open arms (A–C) and the percentage of entries in the open arms 
(D–F) at 15, 30, or 60 days after transplantation. MGE-transplanted mice entered the open arms more at 30 and 60 days after transplan-
tation and spent significantly more time in the open arms at 60 days after transplantation. *p < 0.05 compared with control and dead 
cell groups; one-way ANOVA, followed by post hoc Tukey’s multiple comparison test. 
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the view that transplanted animals explored the maze with 
a normal pattern of motor activity, with no interference in 
memory processes.
Inhibitory Neurons 
Qualitative evaluation of MGE-transplanted cells in 
the host brain was performed by immunohistochemistry 
to confirm the presence of GFP+ transplanted cells in the 
brain parenchyma and to verify their inhibitory identity by 
colocalization with the interneuronal markers NPY, CR, 
and PV. The immunohistochemistry analysis indicated 
that cells that were transplanted into neonate animals had 
survived in the young (at 15 days) and adult hosts brains 
at 30 and 60 days (GFP+ cells with neuronal morphol-
ogy) migrated throughout the parenchyma (found in dif-
ferent areas) and differentiated into inhibitory neurons 
(Figs. 2–4). GFP+ cells found in the brain areas of MGE15 
animals were poorly ramified and showed thin, short pro-
cesses, whereas GFP+ cells from the MGE30 (Fig. 3A–C) 
and MGE60 (Fig. 4A–C) animals displayed thicker and 
longer ramifications of cell processes compared to the 
MGE15 animals (Fig. 2A–C). 
In the MGE15 groups, GFP cells were mainly found in 
the neocortex, striatum, hippocampus, and corpus callo-
sum. The high number of GFP+ cells in the corpus callosum 
suggests a preferential migratory path of these cells at this 
age, which is indicative of their undifferentiated stage. At 
this age, few GFP+ cells colabeled for NPY, PV, and CR 
were found distributed in clusters (NPY and PV) (Fig. 2D–I) 
or scattered (CR) (Fig. 2J–L). At the evaluated time points 
30 and 60 days after transplantation (MGE30 and MGE- 
60), GFP+ cells could be found mainly in the neocortex, 
striatum, septal area (medial septum), hippocampus (CA1 
and dentate gyrus), corpus callosum, periventricular zone 
(ependymal area), thalamus, and amygdala. In MGE30 
animals, GFP cells presented neuronal morphology, with 
long processes (Fig. 3A–C), and many of them expressed 
interneuronal markers for NPY, CR, and PV (Fig. 3F, I, L). 
In the MGE60 group, the GFP cells are clearly identified 
as mature inhibitory cells, and the majority were double-
stained for NPY, CR, and PV (Fig. 4F, I, L).
An estimation of GFP cells in five main regions as well 
as double-staining for interneuronal markers was per-
formed. From the total amount of GFP cells counted in 
the adult animals (P30 and P60), a high percentage of 
GFP+ cells were found in the hippocampus, neocortex, and 
striatum (38.7%, 35.4%, and 17%, respectively). Lower 
percentages of GFP+ cells were found in the amygdala and 
thalamus (respectively, 6.7% and 3%) (Table 1). Although 
the site of injection was confirmed to be in the neocor-
tex layer 3 or 4, clusters of GFP+ cells were found in the 
corpus callosum, corresponding to 24% of the total GFP+ 
cells counted. Substantial percentages of double labeling 
for GFP and inhibitory markers NPY, CR, and PV were 
observed in the hippocampus, neocortex, and striatum 
(respectively, 33.3%, 30.8%, and 28.3%) of the adult ani-
mals. A smaller percentage of GFP+ colabeled cells were 
found in the amygdala (6.3%) and the thalamus (1.26%). 
The total percentage of GFP+/NPY+ was 51.6%, the total 
percentage of GFP+/CR+ was 28.3%, and the total percent-
age of GFP+/PV+ was 20.1%. The percentage of GFP+/
PV+ was 24.4% in the neocortex, 35.4% in the stria-
tum, 28% in the hippocampus, 2.4% in the thalamus, and 
9.7% in the amygdala. The percentage of GFP+/CR+ was 
40% in the neocortex, 17.8% in the striatum, 40% in the 
hippocampus, and 2.2% in the amygdala. Of the GFP+/
NPY+ cells, 34.4% were in the neocortex, 25% in the stri-
atum, 37.5% in the hippocampus, and 3.1% in the amyg-
dala. No GFP+/CR+ or GFP+/NPY+ cells were found in the 
thalamus (Table 1).
DIsCUssION
The main finding of this study is that transplanta-
tion of MGE interneuronal precursor cells into newborn 
mouse brains leads to anxiolytic effects in adulthood. 
Two months after the transplantation of MGE cells into 
postnatal animals, the transplanted cells survived, mig- 
rated throughout the host brain parenchyma and dif-
ferentiated into inhibitory GABAergic interneurons. 
MGE-transplanted cells were detected in the hippocam-
pus, neocortex, striatum, septal area, corpus callosum, 
periventricular zone (ependymal area), amygdala, and 
thalamus. Our results confirm the previous findings of 
migration and differentiation of MGE-transplanted cells 
into inhibitory interneurons in postnatal animals and 
add new data about its behavioral consequences in vivo. 
We did not intend to use an anxiogenic model or per-
form a treatment to decrease anxiety levels by introducing 
MGE precursors in all of the regions involved in anxiety. 
Instead, we questioned whether cortical transplantation 
of MGE cells in newborn animals would affect anxiety-
like behavior and whether an age-dependent effect exists. 
The well-described (1,5,42) migratory potential of these 
cells and their effective dispersion throughout the neo-
cortex justified the experimental design that is delineated 
here. It would be important to know whether this type of 
graft procedure, which has been used by others in animal 
models of epilepsy (5,9,13,39,43), Parkinson’s disease 
(26), and stroke (12), could result in behavioral changes 
such as anxiolysis. 
Studies using grafts of GABAergic precursors derived 
from embryonic telencephalic regions did not consider the 
excitatory role of GABA during development (7). Early 
in development, GABA acting via chloride-permeable 
GABAA channels has depolarizing and excitatory effects 
that result from elevated intracellular chloride concentra-
tions in immature neurons (8). We did not observe any 
changes in the anxiety parameters of mice 15 days after 
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Figure 2. Morphology of MGE-derived GFP+ cells 15 days after transplantation. MGE-derived GFP+ cells 15 days after transplan-
tation (A–C) in the hippocampus (A), striatum (B), and periventricular area (C). Double-stained immunohistochemical analysis of 
grafted GFP+ cells (green) with interneuron-specific markers (red), colocalization of GFP+ and NPY+ (D–F), GFP+ and PV+ (G–I), and 
GFP+ and CR+ (J–L), respectively, in the neocortex (D–F, J–L) and periventricular area (G–I) is demonstrated in the merged images 
(F, I, L). Scale bars: 20 µm. GFP, green fluorescent protein; NPY, neuropeptide Y; PV, parvalbumin; CR, calretinin.
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Figure 3. Morphology of MGE-derived GFP+ cells 30 days after transplantation. Morphology of GFP+ MGE graft-derived cells in 
different brain areas 30 days posttransplantation in the neocortex (A), striatum (B), and CA1 (C). Confocal images showing colocaliza-
tion of GFP (green) and interneuronal markers (red); GFP+ and NPY+ in the neocortex (D–F), GFP+ and PV+ in CA1 (G–I), and GFP+ 
and CR+ in the striatum (J–L). Merged images (F, I, L) indicate double-stained cells, respectively, in the cortex, CA1, and striatum. 
Scale bars: 30 µm.
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Figure 4. Morphology of MGE-derived GFP+ cells 60 days after transplantation GFP+ MGE graft-derived cell morphology in the 
neocortex (A), striatum (B), and dentate gyrus (C) at 60 days posttransplantation. Immunohistochemical colocalization of GFP+ cells 
(green) with NPY+ (red) in the dentate gyrus (D–F), with PV+ (red) in the striatum (G–I), and with CR+ in the neocortex (J–L). Double-
stained cells can be seen in the merge images (F, I, L). Scale bars: 20 µm.
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transplantation. This absence of changes in behavior sug-
gests that the cells were in an undifferentiated stage, hav-
ing a weak functional interaction with the surrounding 
tissue at this age, as reported previously by electrophysi-
ology experiments (1). 
Interestingly, the anxiolytic-like behavior effect began 
to appear at 30 days, presumably when the transplanted 
cells integrated into surrounding tissue, and assumed an 
inhibitory phenotype. In concordance with these findings, 
previous studies showed a significant increase in inhibi-
tory synapses in cortical slices from transplanted animals 
that started 30 days after MGE cell transplantation, for 
example, a time when the interneurons with mature mor-
phology were observed (1,13). De la Cruz and colleagues 
(13) suggest that MGE cells could secrete GABA and act 
early on the control of the inhibitory levels in the cortex. 
These activities could be the reason for the decrease in 
the anxiety behavior patterns in the MGE groups at 30 
and 60 days after transplantation, which is indicated by 
an increase in the percentage of entries into and the time 
spent in the open arms.
Our results from the 30- and 60-day groups (MGE30 
and MGE60) are consistent with a decrease in anxiety-like 
behavior described previously by Cunningham and col-
leagues (11). These authors showed that adult rats tested 
6 weeks after the engraftment of cells derived from the 
lateral ganglionic eminence (LGE) spent more time in the 
open arms of the EPM compared to CTRL animals. Cells 
from the LGE have less migratory potential than those 
from the MGE, and they remained close to the injection 
site when engrafted directly into the amygdaloid nuclei. 
As mentioned previously, MGE-transplanted GFP+ cells 
were found in the neocortex, striatum, septal area, hip-
pocampus (CA1 and dentate gyrus), corpus callosum, 
amygdala, periventricular area, and thalamus. A study of 
the migration of cortical interneurons in the developing 
brains of mice suggested that interneurons derived from 
the MGE showed a wide range of patterns in terms of 
the speed and direction of migration until they were dis-
persed throughout the cortex (35).
Over the last two decades, circuits related to the behav-
ior of fear and anxiety have been described, connecting 
the amygdala with other regions of the brain (33,36). Here, 
low percentages of MGE cells were found in the amyg- 
dala. Nevertheless, the amygdala is not the only structure 
involved in anxiety and fear conditioning. Structures such 
as prefrontal cortex, striatum, and hippocampus are also 
involved (3,4,6,16,17,21,27). Coincidentally, striatum and 
hippocampus showed high percentages of MGE-derived 
cells, although they were not the target structures of the 
injections in the transplantation. The diffuse migration of 
MGE-derived inhibitory cells throughout the cortex was 
sufficient to influence the behavior. This high amount of 
MGE cells within the hippocampus did not produce dif-
ferences in memory tests. In a recent study, the grafting 
of neurospheres from the MGE into the hippocampus did 
not improve learning and memory function in the water 
maze, although the authors suggested that MGE cells have 
an anticonvulsant effect (39).
A number of papers have shown the quantification of 
MGE-derived transplanted cells. Some of these papers 
used lesion strategies or disease models in which the 
precise quantification of the cells is crucial data (5,11–
13,39,43). However, we must consider the possibility of 
a lack of correlation of quantitative data of transplanted 
cells with the observed behavioral response. As proposed 
by De La Cruz and colleagues, the number of MGE trans-
planted cells did not correlate with the degree of attenu-
ation of ictal discharges and the protection from seizures 
found in transplanted animals (13). These results indi-
cate that the mechanism of action of MGE transplants 
to attenuate ictal power is independent of the transplant 
cell number.
The presence of GFP+ cells expressing GABAergic 
markers in different areas indicates that MGE cells could 
migrate throughout the brain parenchyma and differenti-
ate into inhibitory interneurons in vivo. These data confirm 
the findings of other studies, which explore double label-
ing of interneurons expressing calretinin, parvalbumin, and 
NPY in adult animals (1,9,43). The morphological features 
described for the MGE15 cells indicated the immature 
nature of the transplanted cells. Moreover, large numbers 
of GFP+ cells could be detected in the corpus callosum 
in that group, suggesting a migratory pathway of these 
Table 1. Percentage (%) of Medial Ganglionic Eminence (MGE)-Derived Cells
Hippocampus Neocortex Striatum Amygdala Thalamus
GFP+ 38.7 35.4 17 6.7 3
Double-stained cells 33.3 30.8 28.3 6.3 1.26
GFP+/NPY+ 37.5 34.4 25 3.1 0
GFP+/CR+ 40 40 17.8 2.2 0
GFP+/PV+ 28 24.4 35.4 9.7 2.4
Percentage of green fluorescent protein (GFP)-positive and double-stained MGE transplanted cells counted in different 
areas. All percentages are expressed as the total number of GFP+ cells or double-stained interneuronal marker-positive 
cells counted within the five areas. NPY, neuropeptide Y; CR, calretinin; PV, parvalbumin. 
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cells during this stage of development. MGE-derived cells 
expressing interneuronal markers in P15 were rare, pre-
sented in clusters (NPY and PV) or scattered (CR) mainly 
in the cortex. Interestingly, the absence of anxiolytic 
effects at 15 days after transplantation could be attributed 
to the undifferentiated stage of the MGE cells at this age. 
At later time points, 1 and 2 months after transplantation, 
the majority of the GFP+ cells could also be observed in 
other brain regions, and they expressed interneuronal 
markers. GFP+ cells presented morphological character-
istics of inhibitory cells at 30 and 60 days after trans-
plantation (14). In many instances, these cells appeared 
to project to and possibly connect with each other, as 
observed in the granular layer and striatum.
As proposed by others, transplanted MGE-derived pre-
cursor cells not only differentiated into inhibitory inter- 
neurons but also integrated into the preexisting neuronal 
network. In adult animals, the use of interneuronal pre- 
cursor cells from the MGE could repair deficits of the 
inhibitory synaptic function in GABAergic neurotrans-
mission (1,5,38). What could be the in vivo consequences 
to the animal behavior from this increased inhibition? 
Our data suggest that precursor cells derived from the 
MGE and transplanted into neonate animals can change 
the behaviors that are mediated by GABAergic neurons in 
adulthood. That scenario can be explained by decreased 
levels of anxiety-like behavior in the host animal. Our 
study contributes to a better understanding of GABAergic 
circuits in anxiety and provides a new approach for future 
studies on the treatment of disorders in which inhibitory 
synaptic function is altered.
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